Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42 |
filingDate |
2007-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_325951f22a19a5aee8fa8113584d3e1a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37f3e07a46f68a2e1269b5032e73f70d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a903681064a69892b0494e182004e7b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86fcb78a9b500198119c9fc3880c8d41 |
publicationDate |
2013-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2007323799-B2 |
titleOfInvention |
Anti-TSG101 antibodies and their uses for treatment of viral infections |
abstract |
The present invention provides antibodies that bind to the C-terminal region of TSG101. The invention also provides methods of using the TSG101 antibodies for the treatment of viral infections, including HIV and Ebola virus infection. |
priorityDate |
2006-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |